Table 2. Results of the bivariate RMST... | American Society of Hematology

Table 2.

Results of the bivariate RMST analyses

OS-HSCT	5 y ΔRMST (mo)	95% CI	P
DDX41^MutGL vs Int/Adv DDX41^WT	13.6	8.7 to 18.4	<.001
DDX41^MutGL vs Fav DDX41^WT	2.6	–2.7 to 7.9	.3

OS-HSCT	5 y ΔRMST (mo)	95% CI	P
DDX41^MutGL vs Int/Adv DDX41^WT	13.6	8.7 to 18.4	<.001
DDX41^MutGL vs Fav DDX41^WT	2.6	–2.7 to 7.9	.3

RFS-HSCT	3 y ΔRMST (mo)	95% CI	P
DDX41^MutGL vs Int/Adv DDX41^WT	5.8	3.1 to 8.5	<.001
DDX41^MutGL vs Fav DDX41^WT	–1.3	–4.0 to 1.4	.3

RFS-HSCT	3 y ΔRMST (mo)	95% CI	P
DDX41^MutGL vs Int/Adv DDX41^WT	5.8	3.1 to 8.5	<.001
DDX41^MutGL vs Fav DDX41^WT	–1.3	–4.0 to 1.4	.3

Analyses were stratified on the clinical trial.